In addition, the PI3K/AKT/mTOR signaling pathway was inhibited in PRDM8 overexpression by the regulation of NAP1L1 in HCC, which made an antitumor effect (Chen Z. et al., 2018). Here, MTOR is linked to hepatocellular carcinoma.